These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 18356391)

  • 1. Is MMR immunisation safe in chronic Idiopathic thrombocytopenic purpura?
    Bibby AC; Farrell A; Cummins M; Erlewyn-Lajeunesse M
    Arch Dis Child; 2008 Apr; 93(4):354-5. PubMed ID: 18356391
    [No Abstract]   [Full Text] [Related]  

  • 2. Idiopathic thrombocytopenic purpura and the second dose of MMR.
    Stowe J; Kafatos G; Andrews N; Miller E
    Arch Dis Child; 2008 Feb; 93(2):182-3. PubMed ID: 17962371
    [No Abstract]   [Full Text] [Related]  

  • 3. Idiopathic thrombocytopenic purpura and MMR vaccine.
    Miller E; Waight P; Farrington CP; Andrews N; Stowe J; Taylor B
    Arch Dis Child; 2001 Mar; 84(3):227-9. PubMed ID: 11207170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination associated thrombocytopenic purpura in children.
    Rajantie J; Zeller B; Treutiger I; Rosthöj S;
    Vaccine; 2007 Feb; 25(10):1838-40. PubMed ID: 17126957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measles-mumps-rubella vaccination induced thrombocytopenia: a case report and review of the literature.
    Owatanapanich S; Wanlapakorn N; Tangsiri R; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 2014 Sep; 45(5):1053-7. PubMed ID: 25417506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children.
    France EK; Glanz J; Xu S; Hambidge S; Yamasaki K; Black SB; Marcy M; Mullooly JP; Jackson LA; Nordin J; Belongia EA; Hohman K; Chen RT; Davis R;
    Pediatrics; 2008 Mar; 121(3):e687-92. PubMed ID: 18310189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity and safety of measles-mumps-rubella-varicella (MMRV) vaccine followed by one dose of varicella vaccine in children aged 15 months-2 years or 2-6 years primed with measles-mumps-rubella (MMR) vaccine.
    Gillet Y; Steri GC; Behre U; Arsène JP; Lanse X; Helm K; Esposito S; Meister N; Desole MG; Douha M; Willems P
    Vaccine; 2009 Jan; 27(3):446-53. PubMed ID: 19007835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and immunogenicity of a measles-mumps-rubella-varicella vaccine given as a second dose in children up to six years of age.
    Halperin SA; Ferrera G; Scheifele D; Predy G; Stella G; Cuccia M; Douha M; Willems P
    Vaccine; 2009 May; 27(20):2701-6. PubMed ID: 19428882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine administration and the development of immune thrombocytopenic purpura in children.
    Cecinati V; Principi N; Brescia L; Giordano P; Esposito S
    Hum Vaccin Immunother; 2013 May; 9(5):1158-62. PubMed ID: 23324619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MMR vaccine and idiopathic thrombocytopaenic purpura.
    Black C; Kaye JA; Jick H
    Br J Clin Pharmacol; 2003 Jan; 55(1):107-11. PubMed ID: 12534647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up.
    Davidkin I; Jokinen S; Broman M; Leinikki P; Peltola H
    J Infect Dis; 2008 Apr; 197(7):950-6. PubMed ID: 18419470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tracking mothers' attitudes to MMR immunisation 1996-2006.
    Smith A; Yarwood J; Salisbury DM
    Vaccine; 2007 May; 25(20):3996-4002. PubMed ID: 17395344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toward better vaccine safety data and safer vaccination.
    Braun MM
    Pediatrics; 2008 Mar; 121(3):625-6. PubMed ID: 18310214
    [No Abstract]   [Full Text] [Related]  

  • 14. Absence of platelet recovery following Helicobacter pylori eradication in childhood chronic idiopathic thrombocytopenic purpura: a multi-center randomized controlled trial.
    Treepongkaruna S; Sirachainan N; Kanjanapongkul S; Winaichatsak A; Sirithorn S; Sumritsopak R; Chuansumrit A
    Pediatr Blood Cancer; 2009 Jul; 53(1):72-7. PubMed ID: 19301380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of measles, mumps and rubella revaccination in children with juvenile idiopathic arthritis treated with methotrexate and etanercept.
    Borte S; Liebert UG; Borte M; Sack U
    Rheumatology (Oxford); 2009 Feb; 48(2):144-8. PubMed ID: 19074187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [About a case of chronic autoimmune thrombocytopenic purpura associated with toxoplasmosis].
    Lepilleur B; Schoeny M; Melin P; Screve C
    Ann Biol Clin (Paris); 2001; 59(4):493-6. PubMed ID: 11470649
    [No Abstract]   [Full Text] [Related]  

  • 17. A case of symptomatic idiopathic thrombocytopenic purpura during mumps.
    Polat A; Inan M; Cakaloz I; Karakus YT
    Pediatr Hematol Oncol; 2005; 22(3):215-8. PubMed ID: 16020104
    [No Abstract]   [Full Text] [Related]  

  • 18. Re: Recurrent immune thrombocytopenic purpura in children.
    Roganovic J; Letica-Crepulja M; Dordevic L
    Pediatr Hematol Oncol; 2008; 25(3):243-4. PubMed ID: 18432509
    [No Abstract]   [Full Text] [Related]  

  • 19. Subcutaneous anti-D treatment of idiopathic thrombocytopenic purpura in children.
    Kjaersgaard M; Edslev PW; Hasle H
    Pediatr Blood Cancer; 2009 Dec; 53(7):1315-7. PubMed ID: 19722275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sample sizes for self-controlled case series studies.
    Musonda P; Farrington CP; Whitaker HJ
    Stat Med; 2006 Aug; 25(15):2618-31. PubMed ID: 16372391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.